ByYue Wang,
Senior Contributor.
This story is part of Forbes’ coverage of China’s Richest 2025. See the full list here.
China’s growing pipeline of innovative drugs has stoked investor interest in the country’s biotech sector. Amid the optimism, Hansoh Pharmaceutical Group’s 64-year-old chairman and CEO, Zhong Huijuan, rose six spots to No. 16. Her net worth expanded by nearly two-thirds to $19.7 billion on a 70% jump in shares of the Hong Kong-listed company since fortunes were last measured.
China’s richest self-made woman and a former chemistry teacher, Zhong has benefited from bullish sentiment over the company’s new drug candidates and the potentially lucrative deals it has landed with global pharma giants to develop them.
